NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCCIH E-148-2010-0-US-01 TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES US 61/369,229 Abandoned
NCI E-263-2009-0-AU-03 Antiangiogenic Small Molecules and Methods of Use AU National Stage 2010278738 Abandoned
NCI E-263-2009-0-CA-04 Antiangiogenic Small Molecules and Methods of Use CA National Stage 2769038 Abandoned
NICHD E-057-2008-0-JP-12 Use Of Ulipristal For Treating Uterine Fibroids JP National Stage 2010-544688 Issued
NCI E-129-2001-0-US-13 Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressi ng Leukemia Cells. US CON 12/846,625 Abandoned
NICHD E-057-2008-0-BR-05 Use Of Ulipristal For Treating Uterine Fibroids BR National Stage PI0907028-1 Issued
NICHD E-057-2008-0-MX-08 Use Of Ulipristal For Treating Uterine Fibroids MX National Stage MX/a/2010/008270 Issued
NCI E-325-2003-0-US-04 Biofunctionalized Quantum Dots For Biological Imaging US DIV 12/845,177 Abandoned
NCI E-157-2000-0-US-09 Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines US CON 12/845,350 Abandoned
NCI E-217-2010-1-US-01 A Method For The Treatment Of Obesity US 61/368,462 Abandoned
NCI E-003-2007-0-US-08 Engineered Antibody Constant Domain Molecules US National Stage 12/864,758 8580927 Issued PDF
NHLBI E-196-2010-0-US-01 Vortex Countercurrent Chromatography (VCCC) US 61/368,157 Abandoned
NCI E-058-2006-0-US-04 Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid US CON 12/843,238 Abandoned
NICHD E-057-2008-0-IL-06 USE OF 17ALPHA-ACETOXY-11BETA-(4-N,N-DIMETHYLAMINO-PHENYL)-19-NORPREGNA-4,9-DIENE-3,20-DIONE (ULIPRISTAL ACETATE) FOR THE MANUFACTURE OF A MEDICAMENT FOR REDUCING OR STOPPING BLEEDING IN A PATIENT AFFLICTED WITH UTERINE FIBROIDS IL National Stage 207182 Abandoned
NCI E-250-2007-0-US-04 Induced Internalization Of Surface Receptors US National Stage 12/864,492 8420620 Issued PDF
NCI E-070-2005-0-US-04 Inhibitors Of Ubiquitin E1 US DIV 12/842,346 8242160 Issued PDF
NCI E-217-2010-0-US-01 A Method for The Treatment of Obesity US 61/367,299 Abandoned
NCI E-090-2008-2-US-03 Single Nucleotide Polymorphisms Associated with Renal Disease US National Stage 12/864,218 9102983 Abandoned PDF
NIA E-141-2000-0-US-13 Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof US CON 12/841,888 8258172 Expired PDF
NIAID E-184-2010-0-US-01 Use Of Dimethyloxalylglycine (N-methoxyoxoacetyl-glycine Methyl Ester, "DMOG") And Analogs As Inhibitors For Depletion Of The JMJD Family Of Enzymes To Prevent Herpes Simplex Virus Infections And Reactivation From Latency US 61/366,563 Abandoned
NINDS E-306-2003-0-AU-06 DIFFERENTIAL EXPRESSION OF MOLECULES ASSOCIATED WITH ACUTE STROKE AU DIV 2010203139 Abandoned
NCI E-307-2005-0-US-04 CYP1B1 GENOTYPE US National Stage 11/991,878 Abandoned
NCI E-230-2006-0-US-05 Pharmaceutical Composition And Method For Regulating Abnormal Cellular Proliferation US National Stage 12/085,023 8841266 Abandoned PDF
NCATS E-294-2009-0-US-01 Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders (LSDs). LSDs Are A Group Of 40 To 50 Genetic Rare Diseases Caused By The Genetic Mutations Of A Number Of Lysosomal Enzymes And Proteins. US 61/365,712 Abandoned
NCI E-212-2009-0-PCT-02 Method of treating or preventing cancer PCT PCT PCT/US2010/042306 Expired
NIAID E-050-2008-3-US-01 Influenza DNA Vaccination and Methods of Use Thereof US CIP 12/838,292 Abandoned
NCATS E-187-2009-1-US-01 Organic Compounds US 61/365,152 Abandoned
NHLBI E-236-2009-0-EP-04 Emission Detection Method and System For Multi-photon Microscopy EP National Stage 10797972.6 Issued
NHLBI E-236-2009-0-FR-08 Non-Contact Total Emission Detection Method and System For Multi-photon Microscopy FR EP 10797972.6 Issued
NHLBI E-236-2009-0-DE-07 Non-Contact Total Emission Detection Method and System For Multi-photon Microscopy DE EP 10797972.6 Issued
NHLBI E-236-2009-0-GB-09 Non-Contact Total Emission Detection Method and System For Multi-photon Microscopy GB EP 10797972.6 Issued
NHLBI E-236-2009-0-CH-06 Non-Contact Total Emission Detection Method and System For Multi-photon Microscopy CH EP 10797972.6 Issued
NHLBI E-236-2009-0-US-03 Non-contact Total Emission Detection Methods and System For Multi-photon Microscopy US National Stage 13/383,248 8759792 Issued PDF
NHLBI E-236-2009-0-PCT-02 Emission Detection Methods For Multiphoton Microscopy PCT PCT PCT/US2010/041723 Expired
NCI E-205-2010-0-US-01 Photosensitizing Antibody-Fluorophore Conjugate US 61/363,079 Abandoned
NIAID E-289-2007-1-US-02 Sialostatin Mediation Controls Blood-feeding Success Of The Tick Ixodes Scapularis US National Stage 12/671,703 Abandoned
NCI E-008-2008-0-US-07 Methods and Compositions for the Diagnosis And Treatment of Esophageal Adenocarcinomas US National Stage 12/682,318 Abandoned
NIEHS E-180-2011-1-US-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A GENETIC PREDISPOSITION TO PARKINSON DISEASE US 61/361,675 Abandoned
NIDDK E-213-2009-2-PCT-01 Methods Of Modulating Hepatits C Virus Infection PCT PCT COMB PCT/US2010/040918 Expired
NHLBI E-114-2010-0-US-01 Active Adaptive Detuning System For Interventional MRI Devices US 61/360,998 Abandoned
NINDS E-306-2003-1-US-02 DIFFERENTIAL EXPRESSION OF MOLECULES ASSOCIATED WITH ACUTE STROKE US DIV 12/829,229 Abandoned
NIEHS E-146-2010-0-US-01 Matrix Metalloproteinase-9 Blade-1 Region Peptides US 61/360,328 Abandoned
NIBIB E-118-2010-0-US-01 System and Method of Producing Nondiffracting Light Sheets By A Multiplicity Of Spatially Overlapping, Minimally interferring Nondiffracting Optical Beams US 61/360,352 Abandoned
NIAID E-213-2010-0-US-01 Improved HIV Immunogens US 61/359,738 Abandoned
NCI E-169-1999-0-US-05 Peptides and Their Utility in Modulation of Behavior of Cells Expressing Alpha 3 Beta 1 Integrins US DIV 12/824,916 8114406 Abandoned PDF
NIDA E-128-2006-0-US-02 4-Phenylpiperazine Derivatives With Functionalized Linkers As Dopamine D3 Receptor Selective Ligands And Methods of Use US National Stage 12/664,668 8748608 Issued PDF
NEI E-092-2010-0-US-01 Methods of Using Sterculic Acid US 61/358,485 Abandoned
NHLBI E-209-2007-0-US-03 MRI Guidewire US National Stage 12/810,481 8478381 Issued PDF
NCI E-100-2010-0-US-01 Regulation Of Skin Pigmentation By Neuregulin-I (NRG-1) US 61/357,846 Abandoned
NIAID E-019-2018-0-US-02 Complete Sequence Of The Genome Of Avian Parayxovirus Type 2 US ORD 12/803,165 9937196 Issued PDF